Petros Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
Petros Pharmaceuticals, Inc. (PTPI) reported Basic Shares Outstanding (Weighted Average) of 47.39 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 47.39M shares, a 82.82% increase year-over-year.
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 46.22M shares, a 3878.56% increase year-over-year.
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 42.44M shares, a 10396.69% increase year-over-year.
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 42.28M shares, a 10654.16% increase year-over-year.
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 28.07M shares, a 8641.96% increase from fiscal 2024.
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 321.04K shares, a 85.25% decline from fiscal 2023.
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 2.18M shares, a 5.11% increase from fiscal 2022.
- Petros Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 2.07M shares, a 90.11% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 47.39M shares 10-Q · filed 2026-08-13 | 46.90M shares 10-Q · filed 2026-08-13 | 45.35M shares derived: average of 3 quarters · filed 2026-08-13 | 44.58M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 46.22M shares 10-Q · filed 2026-05-13 | 44.33M shares derived: average of 2 quarters · filed 2026-05-13 | 43.65M shares derived: average of 3 quarters · filed 2026-05-13 | 39.22M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 42.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 42.36M shares derived: average of 2 quarters · filed 2026-04-15 | 36.88M shares derived: average of 3 quarters · filed 2026-08-13 | 28.07M shares 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | 42.28M shares 10-Q · filed 2025-11-13 | 34.10M shares derived: average of 2 quarters · filed 2026-08-13 | 23.27M shares 10-Q · filed 2025-11-13 | 17.44M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 25.92M shares 10-Q · filed 2026-08-13 | 13.61M shares 10-Q · filed 2026-08-13 | 9.16M shares derived: average of 3 quarters · filed 2026-08-13 | 6.97M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 1.16M shares 10-Q · filed 2026-05-13 | 783.06K shares derived: average of 2 quarters · filed 2026-05-13 | 653.10K shares derived: average of 3 quarters · filed 2026-05-13 | 563.71K shares derived: average of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | 404.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 398.76K shares derived: average of 2 quarters · filed 2026-04-15 | 364.35K shares derived: average of 3 quarters · filed 2026-04-15 | 321.04K shares 10-K · filed 2026-04-15 | 8.03M shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 393.19K shares 10-Q · filed 2025-11-13 | 9.83M shares 10-Q · filed 2024-11-13 | 344.36K shares derived: average of 2 quarters · filed 2025-11-13 | 293.28K shares 10-Q · filed 2025-11-13 | 7.33M shares 10-Q · filed 2024-11-13 | 814.21K shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 295.52K shares 10-Q · filed 2025-08-14 | 7.39M shares 10-Q · filed 2024-08-14 | 242.89K shares 10-Q · filed 2025-08-14 | 6.07M shares 10-Q · filed 2024-08-14 | 954.54K shares derived: average of 3 quarters · filed 2025-08-14 | 1.25M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 190.28K shares 10-Q · filed 2025-05-15 | 4.76M shares 10-Q · filed 2024-05-15 | 1.28M shares derived: average of 2 quarters · filed 2025-05-15 | 1.56M shares derived: average of 3 quarters · filed 2025-05-15 | 1.70M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 2.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.25M shares derived: average of 2 quarters · filed 2025-03-31 | 2.21M shares derived: average of 3 quarters · filed 2025-03-31 | 2.18M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 2.12M shares 10-Q · filed 2024-11-13 | 2.12M shares derived: average of 2 quarters · filed 2024-11-13 | 2.11M shares 10-Q · filed 2024-11-13 | 2.10M shares derived: average of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 2.12M shares 10-Q · filed 2024-08-14 | 2.10M shares 10-Q · filed 2024-08-14 | 2.09M shares derived: average of 3 quarters · filed 2024-08-14 | 2.09M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 2.09M shares 10-Q · filed 2024-05-15 | 2.08M shares derived: average of 2 quarters · filed 2024-05-15 | 2.08M shares derived: average of 3 quarters · filed 2024-05-15 | 2.08M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 2.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 2.07M shares derived: average of 2 quarters · filed 2024-04-01 | 2.07M shares derived: average of 3 quarters · filed 2024-04-01 | 2.07M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 2.07M shares 10-Q · filed 2023-11-15 | 20.69M shares 10-Q · filed 2022-11-14 | 2.07M shares derived: average of 2 quarters · filed 2023-11-15 | 2.07M shares 10-Q · filed 2023-11-15 | 20.69M shares 10-Q · filed 2022-11-14 | -4.71M shares derived: average of 4 quarters · filed 2023-11-15 | ||
| 2022-06-30 | 2.07M shares 10-Q · filed 2023-08-14 | 20.68M shares 10-Q · filed 2022-08-12 | 2.07M shares 10-Q · filed 2023-08-14 | 20.68M shares 10-Q · filed 2022-08-12 | -6.96M shares derived: average of 3 quarters · filed 2023-08-14 | -2.77M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 2.07M shares 10-Q · filed 2023-05-15 | 20.68M shares 10-Q · filed 2022-05-16 | -11.48M shares derived: average of 2 quarters · filed 2023-05-15 | -4.38M shares derived: average of 3 quarters · filed 2023-05-15 | -832.38K shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -25.03M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-31 | -7.60M shares derived: average of 2 quarters · filed 2023-03-31 | -1.80M shares derived: average of 3 quarters · filed 2023-03-31 | 1.09M shares 10-K · filed 2023-03-31 | 10.89M shares 10-K · filed 2022-03-31 | |||
| 2021-09-30 | 9.83M shares 10-Q/A · filed 2022-11-15 | 9.81M shares derived: average of 2 quarters · filed 2022-11-15 | 9.79M shares 10-Q/A · filed 2022-11-15 | 10.11M shares derived: average of 4 quarters · filed 2022-11-15 | ||||
| 2021-06-30 | 9.80M shares 10-Q · filed 2022-08-12 | 9.78M shares 10-Q · filed 2022-08-12 | 10.20M shares derived: average of 3 quarters · filed 2022-08-12 | 8.51M shares derived: average of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | 9.75M shares 10-Q · filed 2022-05-16 | 10.41M shares derived: average of 2 quarters · filed 2022-05-16 | 8.08M shares derived: average of 3 quarters · filed 2022-05-16 | 6.92M shares derived: average of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | 11.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 7.25M shares derived: average of 2 quarters · filed 2022-03-31 | 5.98M shares derived: average of 3 quarters · filed 2022-03-31 | 5.34M shares 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 3.43M shares 10-Q · filed 2021-11-15 | 3.43M shares derived: average of 2 quarters · filed 2021-11-15 | 3.43M shares 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | 3.43M shares 10-Q · filed 2021-08-16 | 3.43M shares 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | 4.95M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |